When used in the Bionano workflow, DLS supports sensitivity and resolution for structural variant discoveries and accurate and contiguous genome assemblies.
Read More
Rapid whole-genome sequencing is making a difference for acutely ill newborns.
Read MoreA growing number of studies have demonstrated that NGS offers great potential for improving diagnostic accuracy and guiding the selection of patient therapies.
Read More
FDA has expanded the approved use of Lynparza to include the treatment of patients with certain types of breast cancer that have spread and whose tumors have a specific inherited genetic mutation, making it the first drug in its class approved to treat breast cancer.
Read MoreIllumina has signed a contract with Harvard Pilgrim Health Care to accelerate patient access to next-generation sequencing for noninvasive prenatal testing.
Read More